company background image
DCL logo

Cuu Long Pharmaceutical HOSE:DCL Stock Report

Last Price


Market Cap







19 Jun, 2024


Company Financials

Cuu Long Pharmaceutical Joint Stock Company

HOSE:DCL Stock Report

Market Cap: ₫2.2t

DCL Stock Overview

Manufactures and distributes pharmaceutical products primarily in Vietnam.

DCL fundamental analysis
Snowflake Score
Future Growth0/6
Past Performance2/6
Financial Health5/6

Cuu Long Pharmaceutical Joint Stock Company Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Cuu Long Pharmaceutical
Historical stock prices
Current Share Price₫29,900.00
52 Week High₫32,000.00
52 Week Low₫21,700.00
1 Month Change-0.66%
3 Month Change22.79%
1 Year Change24.58%
3 Year Change-37.71%
5 Year Change66.11%
Change since IPO62.04%

Recent News & Updates

Recent updates

Shareholder Returns

DCLVN PharmaceuticalsVN Market

Return vs Industry: DCL exceeded the VN Pharmaceuticals industry which returned 6.8% over the past year.

Return vs Market: DCL exceeded the VN Market which returned 13.4% over the past year.

Price Volatility

Is DCL's price volatile compared to industry and market?
DCL volatility
DCL Average Weekly Movement5.7%
Pharmaceuticals Industry Average Movement3.5%
Market Average Movement4.8%
10% most volatile stocks in VN Market7.4%
10% least volatile stocks in VN Market2.7%

Stable Share Price: DCL has not had significant price volatility in the past 3 months.

Volatility Over Time: DCL's weekly volatility (6%) has been stable over the past year.

About the Company


Cuu Long Pharmaceutical Joint Stock Company manufactures and distributes pharmaceutical products primarily in Vietnam. The company offers analgesic, anti-biotic, anti-histamine, anti-inflammatory, anti-virus, cardiovascular, corticosteroid, cough, dermatology, gastrointestinal, musculoskeletal, and vitamin medicines, as well as capsules and medical equipment. It provides its products under various brands to hospitals through its distribution network, including branches and distributors.

Cuu Long Pharmaceutical Joint Stock Company Fundamentals Summary

How do Cuu Long Pharmaceutical's earnings and revenue compare to its market cap?
DCL fundamental statistics
Market cap₫2.22t
Earnings (TTM)₫69.27b
Revenue (TTM)₫1.19t


P/E Ratio


P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
DCL income statement (TTM)
Cost of Revenue₫962.86b
Gross Profit₫222.25b
Other Expenses₫152.98b

Last Reported Earnings

Mar 31, 2024

Next Earnings Date


Earnings per share (EPS)948.36
Gross Margin18.75%
Net Profit Margin5.85%
Debt/Equity Ratio46.3%

How did DCL perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.